Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.

被引：0
|
作者：
Agrawal, A.
Hannon, R. A.
Cheung, K. L.
Eastell, R.
Robertson, J. F.
机构：
[1] City Hosp, Nottingham NG5 1PB, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47S / 47S
页数：1
相关论文
共 50 条
  • [41] EFFECT ON BONE MINERAL DENSITY OF ORAL BISPHOSPHONATES IN WOMEN WITH OSTEOPOROSIS AND BREAST CANCER TREATED WITH AROMATASE INHIBITORS: ARE BONE TURNOVER MARKERS USEFUL IN THESE PATIENTS?
    Vazquez, I.
    Casado, E.
    Larrosa, M.
    Dalmau, E.
    Segui, M. A.
    Gratacos, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 321 - 321
  • [42] CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS IN BREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE AND IN CONTROL SUBJECTS
    Generali, Daniele
    Tedoldi, Sara
    Bottini, Alberto
    Berruti, Alfredo
    Tampellini, Marco
    Tucci, Marcello
    Allevi, Giovanni
    Torta, Mirella
    Bonardi, Simone
    Milani, Manuela
    Aguggini, Sergio
    Angeli, Alberto
    Dogliotti, Luigi
    ANNALS OF ONCOLOGY, 2004, 15 : 47 - 48
  • [43] Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects.
    Generali, DG
    Tedoldi, S
    Tampellini, M
    Berruti, A
    Torta, M
    Bonardi, S
    Bottini, A
    Tucci, M
    Milani, M
    Angeli, A
    Dogliotti, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [44] Comparative study of the sensitivity of biochemical markers of bone turnover in patients with bone metastases from breast cancer
    Dumon, JC
    Siwek, B
    Kheddoumi, N
    Journé, F
    Barlé, J
    Body, JJ
    BONE, 2001, 28 (05) : S139 - S139
  • [45] Anastrozole increases bone turnover and bone loss in postmenopausal women with breast cancer.
    Confavreux, C.
    Fontana, A.
    Guastalla, J. P.
    Munoz, F.
    Brun, J.
    Delmas, P. D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S347 - S347
  • [46] Which of postmenopausal metastatic breast cancer patients should be treated with fulvestrant in 3rd line hormonal treatment?
    Zbrzezniak, Jolanta
    Jagiello-Gruszfeld, Agnieszka I.
    Czerniawska, Malgorzata
    Szablowska-Siwik, Sylwia
    ANNALS OF ONCOLOGY, 2006, 17 : 87 - 88
  • [47] BONE STATUS OF POSTMENOPAUSAL PATIENTS TREATED WITH HORMONETHERAPY FOR BREAST CANCER: ABOUT 200 CASES
    Assadi, R.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S207 - S208
  • [48] Practical use of bone turnover markers in postmenopausal women
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 364 - 365
  • [49] Statins decrease bone turnover markers in postmenopausal women
    Martinez, J.
    Hernandez, J. L.
    Olmos, J. M.
    Pariente, E.
    Valero, C.
    Garcia, P.
    Nan, D.
    Pinedo, G.
    Gonzalez-Macias, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S444 - S444
  • [50] Bone turnover markers and estradiol level in postmenopausal women
    Sypniewska, G
    Chodakowska-Akolinska, G
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (11) : 1115 - 1119
12345